{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q9HBE4",
      "entity_text" : "IL-21",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ04057",
      "entity_text" : "IL-21R-Fc",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Moreover, therapeutic blockade of IL-21, by the administration of an IL-21R-Fc fusion protein, seems to have a biphasic response characterized by an aggravation of the disease when the treatment is given during early life and an anti-inflammatory effect (decrease in IgG1 serum levels, in proteinuria levels, and in histological glomerulonephritis) when it is administrated later in the disease course.",
  "reading_complete" : "2020-08-04T12:51:46Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T12:45:55Z",
  "trigger" : "blockade",
  "evidence" : [ "blockade of IL-21, by the administration of an IL-21R-Fc" ],
  "pmc_id" : "6056609",
  "score" : 0
}